Source: International Congress 2017 – Highlights on clinical problems in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Shafuddin (Hamilton, New Zealand). Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?. 3643

Member's Comments

No comment yet.

Related content which might interest you: Cardiac biomarkers and outcomes of COPD exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts Source: ERJ Open Res, 7 (1) 00531-2020; 10.1183/23120541.00531-2020 Year: 2021 Long-term outcome following first clinically important deterioration in COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Does aging affect the outcome of comprehensive pulmonary rehabilitation in patients with COPD? Source: Eur Respir J 2003; 22: Suppl. 45, 426s Year: 2003 Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Acute exacerbation of COPD (AECOPD) during pulmonary rehabilitation (PR): impact on outcomes and short-term prediction of risk. Source: International Congress 2017 – Latest insights into chronic care Year: 2017 Can we predict who is mostly likely to re-exacerbate after a COPD exacerbation? Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Statins and outcome of COPD patients after hospitalization for COPD exacerbations Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Determination of poorer outcomes using NIV in acute exacerbations of COPD Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure Year: 2017